Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 6-MTH group results

Nov 6 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2018        Sep 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             17.37               14.13            35.80    
                 (+23.0 pct)         (+7.0 pct)       (+10.8 pct) 
  Operating          2.62              688 mln            5.00    
                (+280.9 pct)         (-50.0 pct)      (+40.6 pct) 
  Recurring          2.67              766 mln            5.20    
                (+248.5 pct)         (-46.9 pct)      (+34.6 pct) 
  Net                1.72              302 mln            3.10    
                (+468.5 pct)         (-54.6 pct)      (+32.8 pct) 
  EPS             14.29 yen           2.51 yen         25.74 yen  
  Ann Div                             4.50 yen         6.00 yen   
  -Q2 div            NIL                 NIL                      
  -Q4 div                             4.50 yen         6.00 yen   
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news